IDRA Annual Retained Earnings
-$735.46 M
+$98.09 M+11.77%
31 December 2021
Summary:
As of February 5, 2025, IDRA annual retained earnings is -$735.46 million, with the most recent change of +$98.09 million (+11.77%) on December 31, 2021. During the last 3 years, it has fallen by -$71.09 million (-10.70%).IDRA Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IDRA Quarterly Retained Earnings
-$748.04 M
-$3.10 M-0.42%
30 September 2022
Summary:
As of February 5, 2025, IDRA quarterly retained earnings is -$748.04 million, with the most recent change of -$3.10 million (-0.42%) on September 30, 2022. Over the past year, it has dropped by -$16.70 million (-2.28%).IDRA Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IDRA Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +11.8% | -2.3% |
| 3 y3 years | -10.7% | -7.2% |
| 5 y5 years | -21.7% | -26.9% |
IDRA Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | +393.0% | +191.3% |
Idera Pharmaceuticals Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | -$748.04 M(+0.4%) |
| June 2022 | - | -$744.95 M(+0.7%) |
| Mar 2022 | - | -$739.64 M(+0.6%) |
| Dec 2021 | -$735.46 M(-11.8%) | -$735.46 M(+0.6%) |
| Sept 2021 | - | -$731.34 M(+0.8%) |
| June 2021 | - | -$725.38 M(+1.1%) |
| Mar 2021 | - | -$717.81 M(-13.9%) |
| Dec 2020 | -$833.55 M(+15.6%) | -$833.55 M(+10.1%) |
| Sept 2020 | - | -$756.85 M(+2.8%) |
| June 2020 | - | -$736.30 M(+3.4%) |
| Mar 2020 | - | -$712.07 M(-1.2%) |
| Dec 2019 | -$720.89 M(+8.5%) | -$720.89 M(+3.3%) |
| Sept 2019 | - | -$697.66 M(+1.6%) |
| June 2019 | - | -$686.52 M(+1.7%) |
| Mar 2019 | - | -$675.35 M(+1.7%) |
| Dec 2018 | -$664.38 M(+9.9%) | -$664.38 M(+1.9%) |
| Sept 2018 | - | -$652.23 M(+1.8%) |
| June 2018 | - | -$640.62 M(+2.6%) |
| Mar 2018 | - | -$624.59 M(+3.3%) |
| Dec 2017 | -$604.49 M(+12.3%) | -$604.49 M(+2.5%) |
| Sept 2017 | - | -$589.57 M(+2.5%) |
| June 2017 | - | -$575.04 M(+3.9%) |
| Mar 2017 | - | -$553.57 M(+2.8%) |
| Dec 2016 | -$538.47 M(+7.7%) | -$538.47 M(-0.2%) |
| Sept 2016 | - | -$539.29 M(+2.5%) |
| June 2016 | - | -$526.39 M(+2.6%) |
| Mar 2016 | - | -$512.90 M(+2.6%) |
| Dec 2015 | -$500.08 M(+10.8%) | -$500.08 M(+2.5%) |
| Sept 2015 | - | -$488.09 M(+2.4%) |
| June 2015 | - | -$476.73 M(+2.7%) |
| Mar 2015 | - | -$464.01 M(+2.8%) |
| Dec 2014 | -$451.53 M(+9.4%) | -$451.53 M(+2.7%) |
| Sept 2014 | - | -$439.61 M(+2.2%) |
| June 2014 | - | -$430.15 M(+2.0%) |
| Mar 2014 | - | -$421.85 M(+2.2%) |
| Dec 2013 | -$412.88 M(+4.6%) | -$412.88 M(+1.5%) |
| Sept 2013 | - | -$406.79 M(+1.2%) |
| June 2013 | - | -$402.06 M(+0.9%) |
| Mar 2013 | - | -$398.46 M(+1.0%) |
| Dec 2012 | -$394.66 M(+5.1%) | -$394.66 M(+1.0%) |
| Sept 2012 | - | -$390.86 M(+1.2%) |
| June 2012 | - | -$386.19 M(+1.0%) |
| Mar 2012 | - | -$382.30 M(+1.8%) |
| Dec 2011 | -$375.42 M(+6.8%) | -$375.42 M(+1.4%) |
| Sept 2011 | - | -$370.26 M(+1.5%) |
| June 2011 | - | -$364.77 M(+1.8%) |
| Mar 2011 | - | -$358.49 M(+1.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2010 | -$351.64 M(+5.4%) | -$351.64 M(+1.7%) |
| Sept 2010 | - | -$345.63 M(+1.4%) |
| June 2010 | - | -$340.92 M(+1.6%) |
| Mar 2010 | - | -$335.62 M(+0.6%) |
| Dec 2009 | -$333.68 M(-2.2%) | -$333.68 M(-1.2%) |
| Sept 2009 | - | -$337.61 M(-0.0%) |
| June 2009 | - | -$337.63 M(-1.1%) |
| Mar 2009 | - | -$341.48 M(+0.1%) |
| Dec 2008 | -$341.23 M(-0.4%) | -$341.23 M(-0.1%) |
| Sept 2008 | - | -$341.59 M(-0.6%) |
| June 2008 | - | -$343.57 M(-0.4%) |
| Mar 2008 | - | -$344.90 M(+0.6%) |
| Dec 2007 | -$342.73 M(+4.0%) | -$342.73 M(+1.3%) |
| Sept 2007 | - | -$338.23 M(+0.9%) |
| June 2007 | - | -$335.06 M(+0.9%) |
| Mar 2007 | - | -$332.05 M(+0.8%) |
| Dec 2006 | -$329.53 M(+5.3%) | -$329.53 M(+1.5%) |
| Sept 2006 | - | -$324.80 M(+1.2%) |
| June 2006 | - | -$320.98 M(+1.4%) |
| Mar 2006 | - | -$316.65 M(+1.2%) |
| Dec 2005 | -$313.00 M(+4.6%) | -$313.00 M(+1.3%) |
| Sept 2005 | - | -$309.12 M(+1.0%) |
| June 2005 | - | -$306.17 M(+1.2%) |
| Mar 2005 | - | -$302.52 M(+1.1%) |
| Dec 2004 | -$299.29 M(+5.4%) | -$299.29 M(+1.0%) |
| Sept 2004 | - | -$296.47 M(+1.4%) |
| June 2004 | - | -$292.46 M(+1.1%) |
| Mar 2004 | - | -$289.29 M(+1.9%) |
| Dec 2003 | -$283.88 M(+8.7%) | -$283.88 M(+2.3%) |
| Sept 2003 | - | -$277.51 M(+1.8%) |
| June 2003 | - | -$272.69 M(+2.0%) |
| Mar 2003 | - | -$267.46 M(+2.4%) |
| Dec 2002 | -$261.14 M(-4.6%) | -$261.14 M(+1.7%) |
| Sept 2002 | - | -$256.82 M(-7.7%) |
| June 2002 | - | -$278.33 M(+1.0%) |
| Mar 2002 | - | -$275.68 M(+0.7%) |
| Dec 2001 | -$273.87 M(+5.3%) | -$273.87 M(+1.5%) |
| Sept 2001 | - | -$269.74 M(+2.5%) |
| June 2001 | - | -$263.22 M(-0.7%) |
| Mar 2001 | - | -$265.21 M(+1.9%) |
| Dec 2000 | -$260.19 M(+2.8%) | -$260.19 M(+0.9%) |
| Sept 2000 | - | -$257.78 M(-1.0%) |
| June 2000 | - | -$260.41 M(+1.3%) |
| Mar 2000 | - | -$256.96 M |
| Dec 1999 | -$253.20 M(+6.2%) | - |
| Dec 1998 | -$238.45 M(+9.1%) | - |
| Dec 1997 | -$218.66 M(+46.6%) | - |
| Dec 1996 | -$149.19 M | - |
FAQ
- What is Idera Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for Idera Pharmaceuticals?
- What is Idera Pharmaceuticals annual retained earnings year-on-year change?
- What is Idera Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for Idera Pharmaceuticals?
- What is Idera Pharmaceuticals quarterly retained earnings year-on-year change?
What is Idera Pharmaceuticals annual retained earnings?
The current annual retained earnings of IDRA is -$735.46 M
What is the all time high annual retained earnings for Idera Pharmaceuticals?
Idera Pharmaceuticals all-time high annual retained earnings is -$149.19 M
What is Idera Pharmaceuticals annual retained earnings year-on-year change?
Over the past year, IDRA annual retained earnings has changed by +$98.09 M (+11.77%)
What is Idera Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of IDRA is -$748.04 M
What is the all time high quarterly retained earnings for Idera Pharmaceuticals?
Idera Pharmaceuticals all-time high quarterly retained earnings is -$256.82 M
What is Idera Pharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, IDRA quarterly retained earnings has changed by -$16.70 M (-2.28%)